Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00315471 · ClinicalTrials.gov registry record
Determining Disease Activity Biomarkers in Individuals With Takayasu's Arteritis
A clinical trial of Takayasu's Arteritis, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 224
- Enrollment target
- 9
- Study locations
NCT00315471: Completed study of Takayasu's Arteritis, sponsored by University of Pennsylvania.
NCT00315471 is a study of Takayasu's Arteritis that has completed, run by University of Pennsylvania. The registered enrollment target is 224 participants, below the 1,451-participant average among 4 other Takayasu's Arteritis trials with a reported enrollment target (85% lower). The trial reports 9 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00315471, a study of Takayasu's Arteritis, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 224 participants
- Enrollment target
- 9
- Study locations
Study Summary
Takayasu's arteritis is a rare disorder that causes swelling and damage to the large arteries in the body, such as the aorta. In order to ensure proper treatment, measuring disease activity is critical. The purpose of this study is to establish new biological markers (biomarkers) to assess the severity of disease in people with Takayasu's arteritis.
Conditions Studied
Study Locations (9)
Massachusetts
- Brigham and Women's Hospital - Boston
- Boston University School of Medicine - Boston
Pennsylvania
- University of Pennsylvania - Philadelphia
- University of Pittsburgh - Pittsburgh
Ontario
- St. Joseph's Healthcare - Hamilton
- Mount Sinai Hospital - Toronto
Minnesota
- Mayo Clinic College of Medicine - Rochester
Ohio
- Cleveland Clinic Foundation - Cleveland
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 224 participants |
| Start Date | 2006-04 |
| Est. Completion | 2019-12 |
What the finished NCT00315471 record still lists
NCT00315471 is an observational study that tracks outcomes without assigning an intervention. The registered 224 participants enrollment target is mid-sized for trials with a published cap, below the 1,451-participant average among 4 other Takayasu's Arteritis trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Takayasu's Arteritis appearing as the primary indexed condition, and to 0 interventions.
NCT00315471 lists 9 locations in 6 states (Massachusetts, Pennsylvania, Ontario).
Frequently Asked Questions
What is clinical trial NCT00315471 about?
NCT00315471 is a clinical study titled "Determining Disease Activity Biomarkers in Individuals With Takayasu's Arteritis". Takayasu's arteritis is a rare disorder that causes swelling and damage to the large arteries in the body, such as the aorta. In order to ensure proper treatment, measuring disease activity is critical. The purpose of this study is to establish new biological markers (biomarkers) to assess the sever...
What is the current status of trial NCT00315471?
This trial is currently completed. The enrollment target is 224 participants. The study started on 2006-04. Estimated completion is 2019-12.
What conditions does trial NCT00315471 study?
This clinical trial studies the following conditions: Takayasu's Arteritis.
Who is sponsoring clinical trial NCT00315471?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00315471 being conducted?
This trial has 9 study locations across Massachusetts, Minnesota, Ohio, Pennsylvania, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Takayasu's Arteritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
One-Time DNA Study for Vasculitis
RECRUITING
-
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
RECRUITING
-
Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis
COMPLETED · Phase 2
-
Vasculitis Illness Perception (VIP) Study
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02706561 · 224 participants · NA
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
- NCT04140344 · 224 participants · NA
The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions
- NCT04915183 · 224 participants · Phase 2
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
- NCT05519878 · 224 participants · NA
Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia